Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Montserrat-de la Paz, S., Garcia-Gimenez, M
GLP-1 receptor agonists are incretin-based therapies that: Enhance glucose-dependent insulin secretion Suppress glucagon release Slow gastric emptying Promote satiety and weight loss Common medications include: Semaglutide Tirzepatide Dulaglutide Liraglutide Their ability to delay gastric emptying is central to both their therapeutic benefits and perioperative risks
Safety review and large meta-analysis have not found an increased UTI risk
Dufresne, C., & Farnworth, E
References Talathi A, Talathi P
US$ 25.05
US$ 27.37
US$ 21.96
